These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9169764)

  • 1. Depletion of alveolar macrophages exacerbates respiratory mycoplasmosis in mycoplasma-resistant C57BL mice but not mycoplasma-susceptible C3H mice.
    Hickman-Davis JM; Michalek SM; Gibbs-Erwin J; Lindsey JR
    Infect Immun; 1997 Jun; 65(6):2278-82. PubMed ID: 9169764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of innate and adaptive immunity in respiratory mycoplasmosis.
    Cartner SC; Lindsey JR; Gibbs-Erwin J; Cassell GH; Simecka JW
    Infect Immun; 1998 Aug; 66(8):3485-91. PubMed ID: 9673224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide decreases nitrotyrosine formation and inhibits nitric oxide production by alveolar macrophages in mycoplasmosis.
    Hickman-Davis JM; Lindsey JR; Matalon S
    Infect Immun; 2001 Oct; 69(10):6401-10. PubMed ID: 11553584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender is a major factor in determining the severity of mycoplasma respiratory disease in mice.
    Yancey AL; Watson HL; Cartner SC; Simecka JW
    Infect Immun; 2001 May; 69(5):2865-71. PubMed ID: 11292700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Vsa proteins modulate susceptibility of Mycoplasma pulmonis to complement killing, hemadsorption, and adherence to polystyrene.
    Simmons WL; Dybvig K
    Infect Immun; 2003 Oct; 71(10):5733-8. PubMed ID: 14500494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsins in Bacteria-Macrophage Interaction: Defenders or Victims of Circumstance?
    Szulc-Dąbrowska L; Bossowska-Nowicka M; Struzik J; Toka FN
    Front Cell Infect Microbiol; 2020; 10():601072. PubMed ID: 33344265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic Programming of Alveolar Macrophages for Protective Antifungal Innate Immunity Against
    Bhagwat SP; Gigliotti F; Wang J; Wang Z; Notter RH; Murphy PS; Rivera-Escalera F; Malone J; Jordan MB; Elliott MR; Wright TW
    Front Immunol; 2018; 9():2131. PubMed ID: 30283457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-17A Exacerbates Disease Severity in BALB/c Mice Susceptible to Lung Infection with Mycoplasma pulmonis.
    Mize MT; Sun XL; Simecka JW
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29986888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory CD4+CD25+ T Cells Dampen Inflammatory Disease in Murine Mycoplasma Pneumonia and Promote IL-17 and IFN-γ Responses.
    Odeh AN; Simecka JW
    PLoS One; 2016; 11(5):e0155648. PubMed ID: 27175511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of alveolar macrophages in CD11c diphtheria toxin receptor mice produces an inflammatory response.
    Roberts LM; Ledvina HE; Tuladhar S; Rana D; Steele SP; Sempowski GD; Frelinger JA
    Immun Inflamm Dis; 2015 Jun; 3(2):71-81. PubMed ID: 26029367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Housing conditions modulate the severity of Mycoplasma pulmonis infection in mice deficient in class A scavenger receptor.
    Booth JL; Umstead TM; Hu S; Dybvig KF; Cooper TK; Wilson RP; Chroneos ZC
    Comp Med; 2014 Dec; 64(6):424-39. PubMed ID: 25527023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of early interactions between Francisella and the host.
    Roberts LM; Tuladhar S; Steele SP; Riebe KJ; Chen CJ; Cumming RI; Seay S; Frothingham R; Sempowski GD; Kawula TH; Frelinger JA
    Infect Immun; 2014 Jun; 82(6):2504-10. PubMed ID: 24686053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin L protects mice from mycoplasmal infection and is essential for airway lymphangiogenesis.
    Xu X; Greenland J; Baluk P; Adams A; Bose O; McDonald DM; Caughey GH
    Am J Respir Cell Mol Biol; 2013 Sep; 49(3):437-44. PubMed ID: 23600672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EPS-I polysaccharide protects Mycoplasma pulmonis from phagocytosis.
    Shaw BM; Daubenspeck JM; Simmons WL; Dybvig K
    FEMS Microbiol Lett; 2013 Jan; 338(2):155-60. PubMed ID: 23190331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Vsa shield of Mycoplasma pulmonis is antiphagocytic.
    Shaw BM; Simmons WL; Dybvig K
    Infect Immun; 2012 Feb; 80(2):704-9. PubMed ID: 22083715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studying the mononuclear phagocyte system in the molecular age.
    Chow A; Brown BD; Merad M
    Nat Rev Immunol; 2011 Oct; 11(11):788-98. PubMed ID: 22025056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role of macrophages and their activation via MyD88-NFκB signaling in lung innate immunity to Mycoplasma pneumoniae.
    Lai JF; Zindl CL; Duffy LB; Atkinson TP; Jung YW; van Rooijen N; Waites KB; Krause DC; Chaplin DD
    PLoS One; 2010 Dec; 5(12):e14417. PubMed ID: 21203444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 2 (TLR2) plays a major role in innate resistance in the lung against murine Mycoplasma.
    Love W; Dobbs N; Tabor L; Simecka JW
    PLoS One; 2010 May; 5(5):e10739. PubMed ID: 20505832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cells interfere with the generation of resistance against mycoplasma respiratory infection following nasal-pulmonary immunization.
    Bodhankar S; Woolard MD; Sun X; Simecka JW
    J Immunol; 2009 Aug; 183(4):2622-31. PubMed ID: 19625649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel IL-17-dependent mechanism of cross protection: respiratory infection with mycoplasma protects against a secondary listeria infection.
    Sieve AN; Meeks KD; Bodhankar S; Lee S; Kolls JK; Simecka JW; Berg RE
    Eur J Immunol; 2009 Feb; 39(2):426-38. PubMed ID: 19180464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.